²é¿´: 941  |  »Ø¸´: 4
±¾Ìû²úÉú 1 ¸ö ²©Ñ§EPI £¬µã»÷ÕâÀï½øÐв鿴
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

GOVERN1688

½ð³æ (ÕýʽдÊÖ)

[ÇóÖú] ÇóÒ»¸ö»¯ºÏÎïµÄ½á¹¹Ê½AZD-3965

AZD-3965µÄ½á¹¹Ê½£¬ÊÇÒ»ÖÖÒ©Îлл

» ÊÕ¼±¾ÌûµÄÌÔÌûר¼­ÍƼö

Ò©Îﻯѧ

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mgfudan

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

mgfudan

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï ¡ï
GOVERN1688: ½ð±Ò+4, ¡ï¡ï¡ï¡ï¡ï×î¼Ñ´ð°¸, лл´óÉñ 2013-08-05 20:58:39
AZD-3965 ÊÇÒ»¸ö×î½ü±»°¢Ë¹Àû¿µÓÐÏÞ¹«Ë¾(ÊÀ½çµÚËÄ´óÖÆÒ©¹«Ë¾)ÑÐÖÆ¿ª·¢µÄÒ»¸ö¿¹Ö×ÁöÐÂÒ©£¬°ÐµãÊÇMCT1¡£Ä¿Ç°ÔÚÁÙ´²IIÆÚÊÔÑé½×¶Î¡£

²Î¿¼ÎÄÏ×ÈçÏ£º
1. Bueno V, Binet I, Steger U, Bundick R, Ferguson D, Murray C, et al. The specific monocarboxylate
transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival
in the mouse. Transplantation 2007; 84:1204-7; PMID:17998878; https://dx.doi.org/10.1097/01.
tp.0000287543.91765.41.

2. Ovens MJ, Davies AJ, Wilson MC, Murray CM,Halestrap AP. AR-C155858 is a potent inhibitor
of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane
helices 7¨C10. Biochem J 2010; 425:523-30; PMID:19929853; https://dx.doi.org/10.1042/BJ20091515
mgfudan
5Â¥2013-08-05 18:27:58
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 5 ¸ö»Ø´ð

liwhite

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï
GOVERN1688: ½ð±Ò+3, ²©Ñ§EPI+1, ¡ïÓаïÖú, Ŷ£¬ÊÇ¿¹°©Ò©ÎÕâ¸öÕæÕÒ²»µ½½á¹¹Ê½£¿ 2013-08-05 08:36:42
ʵÑéÐÔ¿¹°©Ò©Îï°É£¿Õâ¸öÄѶÈÓеã´ó£¬ÊôÓÚÉÌÒµ»úÃܰÉ
2Â¥2013-08-05 08:05:18
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

±ûȲËáõ¥

Í­³æ (СÓÐÃûÆø)

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

¡ï ¡ï ¡ï
GOVERN1688: ½ð±Ò+3, ¡ï¡ï¡ïºÜÓаïÖú, Ŷ£¬Ô­À´ÊÇÕâÑùµÄ£¬Ð»Ð» 2013-08-05 09:18:31
ºÜÃ÷ÏÔ£¬Õâ¸öÊÇÉÌÒµ»úÃÜ£¬ÓпÉÄÜÉæ¼°µ½10ÒÚÃÀµ¶Ñз¢¾­·ÑµÄÎÊÌ⣬Èç¹ûÓÐÈ˸æËßÄãÕâ¸ö½á¹¹Ê½£¬¾ÍÉæ¼°Î¥·¨£¬Òª×øÀεÄ
3Â¥2013-08-05 08:43:15
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mgfudan

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

mgfudan

¡¾´ð°¸¡¿Ó¦Öú»ØÌû

It is an monocarboxylate transporter 1 (MCT1) inhibitors,MCT1 mediates lactate uptake. AZD-3965 is currently being evaluated in phase I/II clinical trials.
mgfudan
4Â¥2013-08-05 18:15:20
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 330Çóµ÷¼Á +4 С²Ä»¯±¾¿Æ 2026-03-18 4/200 2026-03-20 23:13 by JourneyLucky
[¿¼ÑÐ] 316Çóµ÷¼Á +5 ÁºÜçö© 2026-03-19 5/250 2026-03-20 21:26 by ÄãºÃÄãºÃ666
[¿¼ÑÐ] 296Çóµ÷¼Á +5 www_q 2026-03-18 9/450 2026-03-20 20:52 by zhukairuo
[¿¼ÑÐ] 279·ÖÇóµ÷¼Á Ò»Ö¾Ô¸211 +10 chaojifeixia 2026-03-19 11/550 2026-03-20 20:32 by JourneyLucky
[¿¼ÑÐ] 289Çóµ÷¼Á +6 »³èªÎÕè¤l 2026-03-20 6/300 2026-03-20 20:30 by ѧԱ8dgXkO
[¿¼ÑÐ] Ò»Ö¾Ô¸ÄÏÀí¹¤085701»·¾³302Çóµ÷¼ÁԺУ +3 ¿ûè÷ÎÀ¶Ó 2026-03-20 3/150 2026-03-20 19:28 by zhukairuo
[»ù½ðÉêÇë] ѧУÒѾ­Ìá½»µ½NSFC£¬»¹ÄÜÐÞ¸ÄÂ𣿠40+4 babangida 2026-03-19 8/400 2026-03-20 15:58 by babero
[¿¼ÑÐ] 281Çóµ÷¼Á£¨0805£© +14 ÑÌÏ«Ò亣 2026-03-16 25/1250 2026-03-20 15:47 by yuncha
[¿¼ÑÐ] ²ÄÁÏѧ˶318Çóµ÷¼Á +5 February_Feb 2026-03-19 5/250 2026-03-19 23:51 by 23Postgrad
[¿¼ÑÐ] ¸´ÊÔµ÷¼Á +4 z1z2z3879 2026-03-14 6/300 2026-03-19 17:18 by fei626-918
[¿¼ÑÐ] Ò»Ö¾Ô¸Ìì½ò´óѧ»¯Ñ§¹¤ÒÕרҵ£¨081702£©315·ÖÇóµ÷¼Á +11 yangfz 2026-03-17 11/550 2026-03-19 15:06 by houyaoxu
[¿¼ÑÐ] 328Çóµ÷¼Á£¬Ó¢ÓïÁù¼¶551£¬ÓпÆÑо­Àú +4 ÉúÎ﹤³Ìµ÷¼Á 2026-03-16 12/600 2026-03-19 11:10 by ÉúÎ﹤³Ìµ÷¼Á
[¿¼ÑÐ] 085601ר˶£¬×Ü·Ö342Çóµ÷¼Á£¬µØÇø²»ÏÞ +5 share_joy 2026-03-16 5/250 2026-03-18 14:48 by haxia
[¿¼ÑÐ] 278Çóµ÷¼Á +5 ÑÌ»ðÏÈÓÚ´º 2026-03-17 5/250 2026-03-18 08:43 by ÐÇ¿ÕÐÇÔÂ
[¿¼ÑÐ] 334Çóµ÷¼Á +3 Ö¾´æ¸ßÔ¶ÒâÔÚ»úÐ 2026-03-16 3/150 2026-03-18 08:34 by lm4875102
[¿¼ÑÐ] 301Çóµ÷¼Á +4 A_JiXing 2026-03-16 4/200 2026-03-17 17:32 by ruiyingmiao
[¿¼ÑÐ] ¿¼Ñл¯Ñ§Ñ§Ë¶µ÷¼Á£¬Ò»Ö¾Ô¸985 +4 ÕÅvvvv 2026-03-15 6/300 2026-03-17 17:15 by ruiyingmiao
[¿¼ÑÐ] Ò»Ö¾Ô¸£¬¸£ÖÝ´óѧ²ÄÁÏר˶339·ÖÇóµ÷¼Á +3 ľ×ÓmomoÇàÕù 2026-03-15 3/150 2026-03-17 07:52 by laoshidan
[¿¼ÑÐ] 326Çóµ÷¼Á +4 ŵ±´¶û»¯Ñ§½±êéê 2026-03-15 7/350 2026-03-16 17:11 by ŵ±´¶û»¯Ñ§½±êéê
[¿¼ÑÐ] 318Çóµ÷¼Á +3 Yanyali 2026-03-15 3/150 2026-03-16 16:41 by houyaoxu
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û